Sasa unafuata
Hitilafu katika kufuata mtumiaji.
Mtumiaji huyu haruhusu watumiaji kumfuata.
Tayari unamfuata mtumiaji huyu.
Mpango wako wa uanachama unaruhusu tu ufautiliaji 0. Boresha hapa.
Umefaulu kuacha kufuata
Hitilafu wakati wa kuacha kumfuata mtumiaji.
Umefaulu kupendekeza
Hitilafu katika kumpendekeza mtumiaji
Hitilafu fulani imetokea. Tafadhali onyesha upya ukurasa na ujaribu tena.
Barua pepe imethibitishwa kwa ufanisi.
kannur dt,
india
Ni saa 10:51 PM hapa
Alijiunga Januari 4, 2015
5
Mapendekezo
Sivadas V.
@sivubio
5.6
5.6
93%
93%
kannur dt,
india
94%
Kazi Zilizokamilika
97%
Kwa Bajeti
92%
Kwa wakati
20%
Kiwango cha Kuajiriwa Tena
Medical writing * Healthcare Research * Statistics
Wasiliana na Sivadas V. kuhusu kazi yako
Ingia ili kujadili maelezo yoyote kwenye gumzo.
Portfolio
Portfolio
ICH-GCP Certification
Medical Writing
Research Article
Statistical Analysis
Statistical Analysis
BIO-SAFETY LEVEL IN LABORATORY
ICH-GCP Certification
Medical Writing
Research Article
Statistical Analysis
Statistical Analysis
BIO-SAFETY LEVEL IN LABORATORY
Kaguzi
Mabadiliko yamehifadhiwa
Inaonyesha 1 - 5 kutoka kwa 47 - hakiki
$1,000.00 HKD
I
•
$200.00 AUD
Research
Scientific Research
Medical
Research Writing
Medical Writing
+1 zaidi
D
•
$250.00 AUD
Research
Scientific Research
Statistical Analysis
SPSS Statistics
D
•
€100.00 EUR
Research
Scientific Research
Medical
Research Writing
Medical Writing
+1 zaidi
J
•
$230.00 AUD
Health
Public Health
S
•
Uzoefu
Scientist
Mei 2021 - Sasa
Scientist - Mesenchymal Stem Cells (MSC) research
Research Associate
Jun 2017 - Apr 2021 (3 years, 10 months)
Researcher and Lab manager, involved in product development, stem cell research, Osteochondral defect research.
Senior Resident
Mac 2016 - Mac 2017 (1 year)
Senior Resident and Researcher, Cancer Research, Patient management
Elimu
Doctor of Philosophy (Ph. D)
(6 years)
Masters in Biotechnology
(2 years)
Bachelors Degree - Botany
(3 years)
Sifa
Ph.D.
University of Kerala
2014
Ph.D. in Biotechnology (Cancer Biology)
Junior Research Fellowship (JRF)
Council for Scientific and Industrial Research (CSIR)
2007
Qualified as JRF in 2007, awarded by the Council for Scientific and Industrial Research (CSIR)
National Eligibility Test (NET)
University Grants Commission
2006
Secured NET - Lectureship from the reputed University Grants Commission in 2006
Chapisho
Multipotent nature of dental pulp stem cells for the regeneration of varied tissues
Elsevier Publishers
Ample knowledge on the biology of different types of stem cells is of great importance in regenerative medicine and personalized therapy. Recently, Dental Stem Cells (DSCs) are gaining more attention as a stem cell source in regenerative medicine due to its higher clonality, proliferation potential and the capacity to retain stemness even after long-term cryopreservation. Dental Pulp Stem Cells (DPSCs) are the first identified and characterized DSCs.
Dual crosslinked pullulan-gelatin cryogel scaffold for chondrocyte-mediated cartilage repair
IOP Publishers
Cryogels, a subset of hydrogels, have recently drawn attention for cartilage tissue engineering due to its inherent microporous architecture and good mechanical properties. In this study a dual crosslinked pullulan-gelatin cryogel (PDAG) scaffold was synthesized by crosslinking gelatin with oxidized pullulan by Schiff's base reaction followed by cryogelation.
Prognostic implication of the loss of TGFBR2 expression in oral carcinoma
Neoplasma
This study examined the role of Transforming Growth Factor Beta (TGFβ) signalling alterations in oral carcinogenesis and also its influence on the disease prognosis. In presented study, we evaluated the protein-level alterations of core TGFβ signalling members in 20 potentially malignant oral disorders (PMDs) – leukoplakia & submucous fibrosis and 87 oral cancer samples by Western blotting.
3D-printed biphasic scaffolds for the simultaneous regeneration of osteochondral tissues
IOP Publishers
Osteochondral tissue engineering (OCTE) involves the simulation of highly complex tissues with disparate biomechanical properties. OCTE is regarded as the best option for treating osteochondral defects, most of the drawbacks of current treatment methodologies can be addressed by this method. In recent years, the conventional scaffolds used in cartilage and bone regeneration are gradually being replaced by 3D printed scaffolds (3DP).
The microRNA networks of TGFβ signaling in cancer
Springer
In metazoans, the transforming growth factor β (TGFβ) signaling regulates a host of activities ranging from embryonic development to tissue homeostasis. The normal as well as tumor cells respond to this cytokine signaling pathway in a highly context-dependent manner. It acts as a potent tumor suppressor initially by inducing cell cycle arrest and apoptosis.
Glutamic acid-based dendritic peptides for scaffold-free cartilage tissue engineering
ELSEVIER
In the present study, we designed and synthesized three sets of glutamic acid-based dendritic peptides, differing in degree of lipidation as well as branching. Each set constitutes of N-terminal protected as well as corresponding N-deprotected peptides.
Altogether, six peptides [BE12, E12, BE3(12)4, E3(12)4, BE3OMe, E3OMe] were tested for their chondrogenesis enhancing potential in vitro, using rabbit adipose derived mesenchymal stem cells (ADMSCs).
The early manifestation, tumor-specific occurrence and prognostic significance of TGFBR2 aberrant splicing in oral carcinoma
Elsevier (Experimental Cell Research Journal)
Alternative splicing is an important mechanism that can disrupt cell cycle control resulting in tumorigenesis. Although many alterations of Transforming Growth Factor Beta (TGFβ) signaling are reported in cancers, the role of splice aberrations in destabilizing this signaling is the least understood mechanism. In this study, we compared TGFBR2 alternative splicing events in potentially malignant oral disorders (PMDs) and oral squamous cell carcinoma (OSCC) samples with those in normal samples. Interestingly
Novel mutations and expression alterations in SMAD3/TGFBR2 genes in oral carcinoma correlate with poor prognosis
Wiley (Genes Chromosomes Cancer Journal)
Transforming growth factor beta (TGF-β) signaling is a pleiotropic cytokine signaling pathway, which controls cellular activities ranging from embryogenesis to apoptosis. In this study, we have characterized the alterations of TGF-β-SMAD signaling in 97 oral squamous cell carcinoma (OSCC) samples and assessed the association between these alterations and the outcome of the treatment. Genomic level alteration analysis using reverse transcriptase polymerase chain reaction-single-strand conformation polymorphi
Wasiliana na Sivadas V. kuhusu kazi yako
Ingia ili kujadili maelezo yoyote kwenye gumzo.
Udhibitisho
Vyeti
Angalia Wafanyakazi Huru sawia:
Pitia Onyesho Sawia
Mwaliko umetumwa kwa mafanikio
Asante! Tumekutumia kiungo cha kudai mkopo wako bila malipo kwa barua pepe.
Hitilafu fulani imetokea wakati wa kutuma barua pepe yako. Tafadhali jaribu tena.
Imeshindwa kunakili kwenye ubao wa kunakili, tafadhali jaribu tena baada ya kurekebisha ruhusa zako.
Imenakiliwa kwenye ubao wa kunakili.
Onyesho la kukagua linapakia
Ruhusa imetolewa kwa Uwekaji wa Kijiografia.
Muda wako wa kuingia umeisha na umetoka nje. Tafadhali ingia tena.